Funded Tech Companies

AnaptysBio

Wondering who provided funding to AnaptysBio? BioMed Ventures, HBM Healthcare Investments and BVF Partners invested in this innovative biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

AnaptysBio (NASDAQ: ANAB) is a leading biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

1/27/2017

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Hamza Suria

        

Chief Financial Officer

Eric Loumeau

        

Chief Medical Officer

Marco Londei

        

Vice President

Margaret Marino

        

Vice President

Jason Pinkstaff

        

Vice President

Nancy Sacco

        

VP - Manufacturing

Hemant Kumar

        

VP - Regulatory Affairs

Lewis Gryziewicz

        

Company Investors

• BioMed Ventures
• HBM Healthcare Investments
• BVF Partners
• Novo Ventures (Tiba Aynechi)
• Frazier Healthcare Partners (James Topper)
• Cormorant Asset Management
• Novo Ventures (Heath Lukatch)
• Avalon Ventures (Kevin Kinsella)
• Alloy Ventures (Leighton Read)
• WS Investment
• Numenor Ventures (Scott Greer)
• Alloy Ventures (Leighton Reed)

Browse more funded tech companies:

Anapsis | Anaqua

Share this article

About Our VC & M&A Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary